Do NOT start heparin bridging when stopping clopidogrel before surgery in patients with coronary heart disease
Bridging antiplatelet therapy with heparin or low-molecular-weight heparin (LMWH) is not recommended and does not protect against cardiac events while increasing bleeding risk. 1
Why Heparin Bridging is Not Recommended
The evidence is clear that heparin bridging for antiplatelet interruption is fundamentally different from bridging for anticoagulation interruption:
Heparin does not prevent arterial thrombosis effectively: LMWH and unfractionated heparin work primarily on the coagulation cascade, not on platelet function. They cannot substitute for antiplatelet agents in preventing coronary stent thrombosis or acute coronary events 1
Increased bleeding without benefit: Studies show that attempting to bridge with LMWH promotes bleeding, is difficult to reverse, and is less effective than continuing antiplatelet therapy 1
No evidence of efficacy: The 2012 ACCP guidelines specifically address bridging for anticoagulation (warfarin), not antiplatelet agents. The bridging recommendations do not apply to clopidogrel 2
The Correct Approach
For Non-Cardiac Surgery:
Stop clopidogrel 5 days before surgery 1, 2, 3, 4, 5, 6
Continue aspirin perioperatively if possible - this provides some cardiovascular protection 2, 3, 5
Resume clopidogrel within 24-48 hours postoperatively when surgical hemostasis is secure 3, 7
Risk Stratification is Critical:
High thrombotic risk scenarios (where surgery ideally should be delayed):
- Recent coronary stent placement: delay surgery ≥1 month for bare-metal stents, ≥3 months (ideally 6 months) for drug-eluting stents 3, 8
- Recent acute coronary syndrome: delay surgery if clinically stable 7
If surgery cannot be delayed in high-risk patients:
- Consider continuing dual antiplatelet therapy through surgery if bleeding risk permits 2, 3
- For urgent surgery, minimum 24-48 hours off clopidogrel may be acceptable 4, 5, 6
For Cardiac Surgery (CABG):
Continue aspirin throughout the perioperative period 1, 4, 5, 1
Stop clopidogrel 5 days before elective CABG 1, 3, 7, 4, 5, 1, 6
For urgent CABG, minimum 24-48 hours off clopidogrel to reduce major bleeding 4, 5, 6
Common Pitfalls to Avoid
Do not confuse anticoagulation bridging with antiplatelet bridging: The ACCP guidelines on heparin bridging apply to warfarin interruption for atrial fibrillation, mechanical valves, or VTE—not to antiplatelet therapy 2
Do not use LMWH as "aspirin bridging": This practice increases bleeding without providing arterial protection 1
Do not delay restarting clopidogrel postoperatively: Resume as soon as hemostasis permits (typically 24-48 hours) to restore cardiovascular protection 3, 7
Do not stop both aspirin and clopidogrel if avoidable: Maintaining at least aspirin provides some protection during the high-risk perioperative period 2, 3, 5
The Evidence Gap
Recent research has examined LMWH bridging for clopidogrel in abdominal surgery and found slightly higher bleeding rates without clear benefit 9. The practice lacks supporting evidence and contradicts guideline recommendations 1, 10, 11.
The only scenario where heparin has a role is during PCI procedures themselves (for acute anticoagulation during the intervention), not as bridging therapy for interrupted oral antiplatelet agents 12.